tapebrief

GIS · Q1 2026 Earnings

Bearish

General Mills

Reported September 17, 2025

30-second summary

30-second take: Q1 organic net sales fell 3%, which management characterized as in line with internal expectations, and the FY26 organic guide of -1% to +1% was reaffirmed — implying a needed acceleration to roughly flat-to-positive across the remaining three quarters. North America Retail organic sales -5% and Pet organic sales -5% are the gating problem — the Q4 pet inventory build flagged last quarter has now unwound, and Retail showed only modest sequential improvement on the organic line. Management held the FY profit/EPS guide (down 10-15% constant currency) and the FY26 outlook still names the 5% HMM cost-save target and $100M global transformation savings, but now frames growth investments, input cost inflation, and incentive normalization as outpacing those savings. The headline guide stays intact; the underlying read is that category growth is running below long-term projections and the bull case now leans on H2 recovery management has not quantified.

Headline numbers

EPS

Q1 FY2026

$0.86

Revenue

Q1 FY2026

$4.52B

-7.0% YoY

Gross margin

Q1 FY2026

33.9%

Free cash flow

Q1 FY2026

$0.29B

Operating margin

Q1 FY2026

38.2%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$4.52B-7.0%$4.56B-0.8%
EPS$0.86$0.74+16.2%
Gross margin33.9%32.4%+150bps
Operating margin38.2%11.1%+2710bps
Free cash flow$0.29B

Guidance

Company reaffirmed FY2026 profit/EPS guidance (down 10-15% constant currency) but Q1 organic sales missed the implied guidance range at -3%, and two specific cost-saving initiatives were withdrawn from disclosure.

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
Organic Net Sales GrowthQ1 FY2026down 1% to up 1%-3%-2 percentage points below guide rangeMissed

New guidance

MetricPeriodGuideYoY
Net Sales Growth HeadwindFY2026approximately 4 percentage points reduction

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Holistic Margin Management Cost Savings
FY2026
5 percent of cost of goods soldWithdrawn — no replacementWithdrawn
Global Transformation Initiative Savings
FY2026
$100 millionWithdrawn — no replacementWithdrawn

Reaffirmed unchanged this quarter: Adjusted Operating Profit Growth (down 10 to 15 percent in constant currency), Adjusted Diluted EPS (down 10 to 15 percent in constant currency), Free Cash Flow Conversion (at least 95% of adjusted after-tax earnings)

Segment performance

Q1 FY2026
SegmentQ1 FY2026YoY
North America Retail$2.626B-13.0%
International$0.76B+6.0%
North America Pet$0.61B+6.0%
North America Foodservice$0.517B-4.0%
North America Retail Organic Net Sales-5%
North America Pet Organic Net Sales-5%
International Organic Net Sales+4%

Platform metrics

Q1 FY2026
SegmentQ1 FY2026
Organic Net Sales Growth-3%
Pound Share PerformanceHeld or gained in 8 of top 10 U.S. categories

Profitability

Q1 FY2026
SegmentQ1 FY2026
Adjusted Operating Profit$711.2 million
Adjusted Operating Profit Margin15.7%
Operating Cash Flow$397 million

Management tone

No transcript was available for this quarter; the read below is anchored in the press-release language versus the Q4 FY25 outlook commentary.

From "investment year to restart growth" to "category growth below long-term projections." Last quarter management framed FY26 as a discrete reset year to fund Blue Buffalo fresh, with the bull case anchored on returning North America Retail to volume growth. This quarter's release explicitly flags that "category growth is expected to be below long-term projections, reflecting less benefit from price/mix amid a continued challenging consumer backdrop." The locus of the problem has shifted from "our execution" to "the category" — a meaningfully different posture and one that historically precedes guide cuts in CPG.

The FY guide reaffirmation reads as commitment, not confidence. Holding the -10 to -15% EPS guide after a Q1 organic sales print of -3% requires the H2 recovery management has not quantified and offsetting margin actions they have not specified. Adjusted operating margin of 15.7% — versus an FY25 base of 17.8% in the year-ago quarter — was helped in Q1 by favorable phasing of input cost inflation and International timing benefits that are explicitly flagged to unwind largely in Q2.

Answers to last quarter's watch list

North America Retail organic sales trajectory — Organic improved from -7% in Q4 to -5% in Q1; reported worsened from -10% to -13% as the yogurt-divestiture headwind landed. Pound share held or gained in 8 of 10 top categories. Status: Partially resolved
Adjusted gross margin direction — Adjusted gross margin was 34.2%, down 120 bps YoY, driven by higher input costs partially offset by net price realization and mix (including the yogurt divestiture mix benefit). GAAP at 33.9% (-90 bps). Above the 32% line we flagged as the breaking point; sustainability into Q2 — when International timing benefits and input cost phasing reverse — is the real read. Status: Continue monitoring
Blue Buffalo fresh launch metrics — The release notes the launch is "just now starting to ship to customers" but did not quantify distribution build, launch advertising, or early velocity. Pet -5% organic suggests the launch is not yet a tailwind. Status: Not resolved
SG&A growth rate vs. top line — SG&A was down 1% YoY in dollars; as a percent of net sales it rose 110 bps to 18.7%, reflecting deleverage from the revenue decline. Status: Continue monitoring
Tariff mitigation progress — Not quantified beyond inclusion in the "input cost inflation (including the impact of tariffs)" language in the FY outlook. Status: Not resolved
Pet segment growth durability — Pet organic flipped from +12% in Q4 to -5% in Q1, confirming the Q4 inventory build unwound as feared. The reinvestment funding model — pet strength offsetting Retail weakness — is not currently working. Status: Resolved negatively

What to watch into next quarter

Whether the FY26 organic sales guide (-1% to +1%) is formally cut. Q1 at -3% requires the remaining three quarters to average roughly 0% to +2%; if Q2 prints another negative organic number, the FY range becomes mathematically untenable and a cut becomes the base case.

Cost-save execution against the named anchors. The 5% HMM and $100M transformation targets remain in the outlook but are now explicitly framed as being outpaced by growth investments, input cost inflation, and incentive normalization. Watch whether Q2 commentary still references both anchors and whether the gap between savings and reinvestment widens.

North America Pet organic sales ex-Whitebridge. Q1 -5% organic was the inventory unwind; Q2 will show the clean underlying trend. If organic Pet stays negative in Q2, the Blue Buffalo fresh launch thesis is in trouble before the national rollout is fully in market.

Adjusted gross margin print. 34.2% in Q1 is the lone operational bright spot, but Q2 absorbs the unwind of favorable input cost phasing and International timing benefits. If Q2 adjusted gross margin holds at or above 33%, the targeted-value-investment framing survives; below 32%, broad price erosion is the read.

Any quantification of the Blue Buffalo fresh national launch. Distribution, trial metrics, or launch spend disclosure — management has declined twice now. A third quarter of silence means investors will be asked to take FY27+ payoff on faith.

Q2 organic sales for North America Retail specifically. Two consecutive quarters of -5% to -7% organic in the largest segment, against a stated "return to volume growth" thesis, would force a re-underwriting of the FY26 investment-year framing.

Sources

  1. General Mills Q1 fiscal 2026 press release (SEC filing): https://www.sec.gov/Archives/edgar/data/40704/000119312525205477/d945465dex99.htm
  2. Tapebrief Q4 FY2025 brief (June 25, 2025) for prior guidance baselines and watch list.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.